Children’s food allergy treatment should be just as unique as they are.

Unlike other food allergy treatment programs that are designed for an “average patient,” our precision medicine Tolerance Induction Program involves an assessment of each patient’s immune system to predict how that patient will respond to specific food proteins, resulting in unmatched predictability, safety and long-term success.

Watch presentation on precision medicine

SoCal Food Allergy’s OIT program is based on the concept of precision medicine. Supported by both the U.S. Food and Drug Administration and National Institutes of Health, precision medicine is an innovative approach that takes into account individual patient differences, providing clinicians with the ability to select which treatment will work best for each patient.

Clinical trials, which typically study the effects of a one-size-fits-all approach to medicine, have been the mainstay of drug-based therapy development in the U.S. for decades. The focus on a single drug for one entire condition is common, but often not effective. Many patients who receive a drug do not receive the desired benefit.

Clinical trials related to food allergy have several drawbacks. Access is extremely limited, and many participants are excluded due to their age, the severity of their allergies, other conditions, or other reasons. Trial parameters often require clinicians to establish an “eliciting dose” by putting the participants selected into potentially life-threatening anaphylaxis before treatment. Many of the participants who continue with a trial receive a placebo instead of treatment. Those participants who are treated receive the trial’s preset, standardized protocol, regardless of their individual needs, preferences, or resulting side-effects. Trial goals are study-based, not patient-based, and patients receive no follow-up care or long-term monitoring. For these reasons, many families decide against participating in clinical trials.

At SoCal Food Allergy, our treatment model is the polar opposite. We look at our patients one at a time by utilizing a battery of diagnostic tests, an extensive patient history, and an assessment of the immune system’s reaction to food. Then we develop a customized, strategic protocol for each patient. With that bank of knowledge, there is no need for a patient to endure anaphylaxis.

Discover The Process
Get To Know Who We Are
team + leadership